HopeStage
Back to overview

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Topics
More filters
27277studies shown
Showing 6,217-6,228 of 27,277
Drug study icon
CompletedEUCTR 2013-001695-38

A 6-WEEK RANDOMIZED, PARALLEL, DOUBLE-BLIND, PLACEBO-CONTROLLED, FIXED-DOSE, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LURASIDONE IN ADOLESCENT SUBJECTS WITH SCHIZOPHRENIA

This study has finished and is no longer accepting participants.

Recruitment status comes from the linked ClinicalTrials.gov record. Both registries list the identifiers for the same study.

Multiple locations, including Dothan
SchizophreniaHistorical research recordAges 13–17
Countries
United States, France, United Kingdom, + 13 others
Sponsor
SUNOVION PHARMACEUTICALS INC.
Drug study icon
CompletedNCT03465787

Lurasidone HCL for schizophrenia

What is this study about?

Researchers compared Lurasidone HCL 160 mg and Quetiapine XR 600 mg to find out how the approaches affected psychotic symptoms in people with schizophrenia.

This study has finished and is no longer accepting participants.

In Seoul
SchizophreniaMedication studyAges 19–75
Countries
South Korea
Sponsor
Bukwang Pharmaceutical
Drug study icon
WithdrawnNCT03536390

Safety study of Safety and Efficacy of Methylphenidate HCl ERCT in ADHD

What is this study about?

This study evaluates the safety and effectiveness of Methylphenidate Hydrochloride (HCl) Extended Release Chewable Tablet (ERCT) for people with ADHD.

This study was withdrawn before enrollment.

Location not clearly listed
ADHDMedication studyAges 48–69 months
Countries
Sponsor
Pfizer
Drug study icon
WithdrawnNCT03580005

Safety study of Safety and Efficacy of Quillichew ERCT in ADHD

Official study title

A Phase 4, Double-blind, Randomized, Parallel Group, Placebo-controlled Study Of The Efficacy And Safety Of Quillichew (Methylphenidate Hydrochloride (Hcl)) Extended Release Chewable Tablets (Erct) In 4-5 Year Old Children With Attention Deficit Hyperactivity Disorder (Adhd)

This study was withdrawn before enrollment.

Location not clearly listed
ADHDMedication studyAges 4–5
Countries
Sponsor
Pfizer
Drug study icon
CompletedEUCTR 2004-000750-22

A 6-week, International, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Phase IIIb Study of the Efficacy and Safety of Quetiapine Fumarate (SEROQUEL) Immediate-release T...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Germany
SchizophreniaHistorical research record
Countries
Germany
Sponsor
AstraZeneca AB
Drug study icon
CompletedEUCTR 2005-003002-28

A 7 week multicenter, double-blind, randomized, placebo-controlled cross-over evaluation of the efficacy and safety of a modified-release oral dosage form of methylphenidate-HCl, Ritalin LA® (20 mg...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Germany
ADHDHistorical research record
Countries
Germany
Sponsor
Novartis Pharma GmbH
Behavioral study icon
Active Not RecruitingNCT07112001

App-based counselling for anxiety and depression in people with HIV

About this title

A Behavioral mHealth Intervention for People With HIV With Anxiety and Depression

Read the official source — NCT07112001
Official study title

Adaptation and Implementation of a Behavioral mHealth Intervention to Reduce Anxiety and Depression and End the HIV Epidemic in the Rural South

This study is no longer accepting new participants.

In Gainesville
Depression, AnxietyBehavioural studyAges 18–90
Countries
United States
Sponsor
University of Florida
Behavioral study icon
CompletedACTRN12613000428763

A Behavioural Therapy (BT) Sleep Intervention with Cognitive Components to Treat Insomnia in Rural NSW involving Practice Nurses: A Study

Official study title

A Behavioural Therapy (BT) Sleep Intervention with Cognitive Components to Treat Insomnia in Rural NSW involving Practice Nurses: A Pilot Study

This study has finished and is no longer accepting participants.

In Australia
Mental healthInterventional studyAges 18+
Countries
Australia
Sponsor
Centre for Integrated Research and Understanding of Sleep - Seed Funding Grant

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.